Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: SVY

Global Innovation Management Industry (2020 to 2027) - Market Trajectory & Analytics


DUBLIN, Aug. 5, 2020 /PRNewswire/ -- The "Innovation Management - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The publisher brings years of research experience to the 7th edition of this report. The 108-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Innovation Management Market to Reach $3.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Innovation Management estimated at US$682.5 Million in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at aCAGR of 26.2% over the period 2020-2027.

Software, one of the segments analyzed in the report, is projected to record 25.9% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 27.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $204.5 Million, While China is Forecast to Grow at 25.5% CAGR

The Innovation Management market in the U.S. is estimated at US$204.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$602.2 Million by the year 2027 trailing a CAGR of 25.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 23.5% and 22.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 18.4% CAGR.

Competitors identified in this market include, among others:

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Total Companies Profiled: 42

For more information about this report visit https://www.researchandmarkets.com/r/73lrxi

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:45
The "Laboratory Filtration Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Laboratory Filtration Equipment Market to Reach $3 Billion by 2030 The global market for Laboratory...

at 07:42
Reference is made to Akastor ASA's (OSE: AKAST) announcement dated 18 April 2024 on the arbitration award issued in respect of the DRU contracts. Payment of the principal sums awarded, in total USD 108 million (exclusive interest), has now been...

at 07:40
The "Global Weight Loss Drugs Market: Analysis By Product Type, By Drug Type, By Distribution Channel, By End User, By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's...

at 07:35
IonQ , a leader in the quantum computing industry, announced today the appointment of Peter Chapman as its next Chairman of the Board and Harry You as the Lead Independent Director of the Board, effective at the close of IonQ's upcoming Annual...

at 07:35
Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company's proprietary Targeted RNAi Molecule...

at 07:35
Reports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable Impact of $0.08 Per Share Related to Acquired IPR&D and...



News published on and distributed by: